Search results
AstraZeneca pulls its COVID-19 vaccine from the European market
Stamford Advocate· 5 days agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine...
Novavax Stock Doubles on $1.2B Sanofi Deal for COVID-19, Flu Vaccines
Investopedia· 4 days agoSanofi agreed to pay Novavax $500 million upfront, with another $700 million in possible payments...
AstraZeneca withdraws Covid-19 vaccine, citing low demand
WKBT La Crosse· 6 days agoAstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a...
AstraZeneca pulls its COVID-19 vaccine from the European market
Newsday· 6 days agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 4 days agoUnder the terms of the agreement, Sanofi will begin to book sales of Novavax’s COVID-19 vaccine...
AstraZeneca withdraws its vaccine to protect against COVID-19 worldwide
CBC via Yahoo News· 6 days agoAstraZeneca says it is withdrawing Vaxzevria, its vaccine to protect against COVID-19, from global...
Expert reaction: AstraZeneca withdraws its COVID-19 vaccine
Cosmos· 3 days agoAstraZeneca developed the first vaccine for COVID-19, beating the competition, but this week they’ve...
AstraZeneca to withdraw its COVID-19 vaccine; says dip in demand is the reason
WSB-TV 2 Atlanta· 6 days agoThe Oxford-AstraZeneca COVID-19 vaccine is being withdrawn worldwide, according to the company. The...
AstraZeneca to withdraw Covid-19 vaccine globally
Pharmaceutical Technology via Yahoo Finance· 6 days agoAstraZeneca has begun the global withdrawal of its Covid-19 vaccine, Vaxzevria, citing a surplus of updated vaccines
Novavax, Sanofi Ink Deal to Commercialize COVID-19 Vaccine to Jointly Produce Combination Shots -...
EconoTimes· 4 days agoNovavax, Inc., a biotechnology company headquartered in Gaithersburg, Maryland, revealed on Friday,...